US Stock MarketDetailed Quotes

CPRX Catalyst Pharmaceuticals

Watchlist
  • 24.230
  • +1.070+4.62%
Close Mar 21 16:00 ET
  • 24.300
  • +0.070+0.29%
Post 20:01 ET
2.94BMarket Cap18.50P/E (TTM)

Catalyst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
67.00%239.81M
27.37%70.88M
61.48%72.87M
108.54%64.14M
164.50%31.93M
23.74%143.6M
38.85%55.65M
9.27%45.13M
17.42%30.75M
42.37%12.07M
Net income from continuing operations
129.50%163.89M
60.53%55.94M
242.65%43.88M
8.03%40.79M
-21.28%23.28M
-14.05%71.41M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
Depreciation and amortization
14.88%37.77M
3.45%9.46M
10.31%9.45M
10.09%9.44M
42.88%9.43M
2,553.83%32.88M
1,386.67%9.14M
1,449.37%8.57M
23,062.16%8.57M
19,311.76%6.6M
Deferred tax
47.31%-9.39M
189.35%2.56M
38.44%-8.58M
50.20%-1.61M
-14.94%-1.75M
-460.91%-17.82M
-31.28%883K
-1,592.83%-13.94M
-496.45%-3.24M
-179.91%-1.52M
Other non cash items
-100.67%-557K
-98.70%32K
-101.26%-1.01M
212.31%203K
13.92%221K
1,794.06%83.23M
3,814.29%2.47M
1,816.67%80.5M
-10.96%65K
234.48%194K
Change In working capital
182.83%30.91M
-41.90%4.45M
832.98%26.47M
155.06%8.65M
66.31%-8.65M
-371.86%-37.32M
-28.58%7.65M
-133.80%-3.61M
-1,687.66%-15.7M
-196.40%-25.67M
-Change in receivables
72.23%-11.96M
-31.93%-7.21M
79.17%-1.09M
135.35%3.32M
69.61%-6.98M
-1,027.62%-43.08M
-395.92%-5.47M
-2,201.20%-5.25M
-1,073.47%-9.39M
-483.85%-22.96M
-Change in inventory
17.77%-3.9M
107.20%476K
-216.72%-2M
558.39%1.94M
-846.79%-4.31M
-544.98%-4.74M
-2,121.10%-6.61M
139.00%1.72M
-1,739.13%-423K
1,241.86%577K
-Change in prepaid assets
-46.82%-8.5M
-286.05%-2.66M
196.96%5.17M
-476.76%-9.81M
-533.51%-1.21M
-617.72%-5.79M
203.26%1.43M
-1,056.55%-5.33M
-392.60%-1.7M
66.07%-191K
-Change in payables and accrued expense
234.81%55.65M
-24.24%13.93M
358.67%24.49M
423.90%13.28M
231.07%3.94M
-5.56%16.62M
41.96%18.39M
-42.18%5.34M
-797.37%-4.1M
27.27%-3.01M
-Change in other current liabilities
-9.17%-369K
-9.30%-94K
-9.30%-94K
-9.52%-92K
-8.54%-89K
-10.10%-338K
-10.26%-86K
-8.86%-86K
-9.09%-84K
-12.33%-82K
Cash from discontinued investing activities
Operating cash flow
67.00%239.81M
27.37%70.88M
61.48%72.87M
108.54%64.14M
164.50%31.93M
23.74%143.6M
38.85%55.65M
9.27%45.13M
17.42%30.75M
42.37%12.07M
Investing cash flow
Cash flow from continuing investing activities
99.81%-556K
99.77%-88K
99.72%-259K
-10K
99.88%-199K
-3,287.12%-293.5M
-38.32M
-70,215.91%-92.82M
0
-162.37M
Net PPE purchase and sale
-140.69%-556K
5.38%-88K
-304.69%-259K
---10K
-168.92%-199K
-696.55%-231K
---93K
---64K
--0
---74K
Net intangibles purchase and sale
--0
--0
----
----
----
---81.51M
---2.23M
----
----
----
Net investment purchase and sale
--0
--0
----
----
----
-169.99%-13.47M
--0
----
----
----
Net other investing changes
----
----
----
----
----
-1,882.93%-198.29M
---36M
--0
--0
---162.29M
Cash from discontinued investing activities
Investing cash flow
99.81%-556K
99.77%-88K
99.72%-259K
---10K
99.88%-199K
-3,287.12%-293.5M
---38.32M
-70,215.91%-92.82M
--0
---162.37M
Financing cash flow
Cash flow from continuing financing activities
1,395.62%140.67M
766.62%4.43M
41.01%-5.97M
640.65%1.16M
94,563.76%141.05M
-740.91%-10.86M
-129.52%-665K
-354.19%-10.13M
92.85%-214K
109.61%149K
Net common stock issuance
--140.7M
--0
--0
--0
--140.7M
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
384.06%13.52M
763.49%5.98M
1,776.42%3.98M
229.17%2.03M
19.84%1.52M
-70.82%2.79M
-78.35%693K
-94.68%212K
-55.42%617K
27.00%1.27M
Net other financing activities
0.70%-13.55M
-14.21%-1.55M
3.74%-9.95M
-5.17%-874K
-5.00%-1.18M
-73.32%-13.65M
82.71%-1.36M
---10.34M
---831K
---1.12M
Cash from discontinued financing activities
Financing cash flow
1,395.62%140.67M
766.62%4.43M
41.01%-5.97M
640.65%1.16M
94,563.76%141.05M
-740.91%-10.86M
-129.52%-665K
-354.19%-10.13M
92.85%-214K
109.61%149K
Net cash flow
Beginning cash position
-53.87%137.64M
265.65%442.33M
110.13%375.69M
109.39%310.41M
-53.87%137.64M
74.05%298.4M
-52.76%120.97M
-15.23%178.79M
-16.89%148.25M
74.05%298.4M
Current changes in cash
336.33%379.92M
351.38%75.22M
215.26%66.64M
113.76%65.28M
215.07%172.78M
-226.63%-160.76M
-60.63%16.67M
-228.04%-57.82M
-6.15%30.54M
-2,267.58%-150.15M
End cash Position
276.03%517.55M
276.03%517.55M
265.65%442.33M
110.13%375.69M
109.39%310.41M
-53.87%137.64M
-53.87%137.64M
-52.76%120.97M
-15.23%178.79M
-16.89%148.25M
Free cash flow
286.79%239.25M
32.74%70.79M
312.17%72.61M
108.51%64.13M
164.47%31.73M
-46.68%61.86M
33.07%53.33M
-182.86%-34.22M
17.55%30.75M
41.50%12M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 67.00%239.81M27.37%70.88M61.48%72.87M108.54%64.14M164.50%31.93M23.74%143.6M38.85%55.65M9.27%45.13M17.42%30.75M42.37%12.07M
Net income from continuing operations 129.50%163.89M60.53%55.94M242.65%43.88M8.03%40.79M-21.28%23.28M-14.05%71.41M36.80%34.84M-235.24%-30.76M74.67%37.76M123.31%29.57M
Depreciation and amortization 14.88%37.77M3.45%9.46M10.31%9.45M10.09%9.44M42.88%9.43M2,553.83%32.88M1,386.67%9.14M1,449.37%8.57M23,062.16%8.57M19,311.76%6.6M
Deferred tax 47.31%-9.39M189.35%2.56M38.44%-8.58M50.20%-1.61M-14.94%-1.75M-460.91%-17.82M-31.28%883K-1,592.83%-13.94M-496.45%-3.24M-179.91%-1.52M
Other non cash items -100.67%-557K-98.70%32K-101.26%-1.01M212.31%203K13.92%221K1,794.06%83.23M3,814.29%2.47M1,816.67%80.5M-10.96%65K234.48%194K
Change In working capital 182.83%30.91M-41.90%4.45M832.98%26.47M155.06%8.65M66.31%-8.65M-371.86%-37.32M-28.58%7.65M-133.80%-3.61M-1,687.66%-15.7M-196.40%-25.67M
-Change in receivables 72.23%-11.96M-31.93%-7.21M79.17%-1.09M135.35%3.32M69.61%-6.98M-1,027.62%-43.08M-395.92%-5.47M-2,201.20%-5.25M-1,073.47%-9.39M-483.85%-22.96M
-Change in inventory 17.77%-3.9M107.20%476K-216.72%-2M558.39%1.94M-846.79%-4.31M-544.98%-4.74M-2,121.10%-6.61M139.00%1.72M-1,739.13%-423K1,241.86%577K
-Change in prepaid assets -46.82%-8.5M-286.05%-2.66M196.96%5.17M-476.76%-9.81M-533.51%-1.21M-617.72%-5.79M203.26%1.43M-1,056.55%-5.33M-392.60%-1.7M66.07%-191K
-Change in payables and accrued expense 234.81%55.65M-24.24%13.93M358.67%24.49M423.90%13.28M231.07%3.94M-5.56%16.62M41.96%18.39M-42.18%5.34M-797.37%-4.1M27.27%-3.01M
-Change in other current liabilities -9.17%-369K-9.30%-94K-9.30%-94K-9.52%-92K-8.54%-89K-10.10%-338K-10.26%-86K-8.86%-86K-9.09%-84K-12.33%-82K
Cash from discontinued investing activities
Operating cash flow 67.00%239.81M27.37%70.88M61.48%72.87M108.54%64.14M164.50%31.93M23.74%143.6M38.85%55.65M9.27%45.13M17.42%30.75M42.37%12.07M
Investing cash flow
Cash flow from continuing investing activities 99.81%-556K99.77%-88K99.72%-259K-10K99.88%-199K-3,287.12%-293.5M-38.32M-70,215.91%-92.82M0-162.37M
Net PPE purchase and sale -140.69%-556K5.38%-88K-304.69%-259K---10K-168.92%-199K-696.55%-231K---93K---64K--0---74K
Net intangibles purchase and sale --0--0---------------81.51M---2.23M------------
Net investment purchase and sale --0--0-------------169.99%-13.47M--0------------
Net other investing changes ---------------------1,882.93%-198.29M---36M--0--0---162.29M
Cash from discontinued investing activities
Investing cash flow 99.81%-556K99.77%-88K99.72%-259K---10K99.88%-199K-3,287.12%-293.5M---38.32M-70,215.91%-92.82M--0---162.37M
Financing cash flow
Cash flow from continuing financing activities 1,395.62%140.67M766.62%4.43M41.01%-5.97M640.65%1.16M94,563.76%141.05M-740.91%-10.86M-129.52%-665K-354.19%-10.13M92.85%-214K109.61%149K
Net common stock issuance --140.7M--0--0--0--140.7M--0--0--0--0--0
Proceeds from stock option exercised by employees 384.06%13.52M763.49%5.98M1,776.42%3.98M229.17%2.03M19.84%1.52M-70.82%2.79M-78.35%693K-94.68%212K-55.42%617K27.00%1.27M
Net other financing activities 0.70%-13.55M-14.21%-1.55M3.74%-9.95M-5.17%-874K-5.00%-1.18M-73.32%-13.65M82.71%-1.36M---10.34M---831K---1.12M
Cash from discontinued financing activities
Financing cash flow 1,395.62%140.67M766.62%4.43M41.01%-5.97M640.65%1.16M94,563.76%141.05M-740.91%-10.86M-129.52%-665K-354.19%-10.13M92.85%-214K109.61%149K
Net cash flow
Beginning cash position -53.87%137.64M265.65%442.33M110.13%375.69M109.39%310.41M-53.87%137.64M74.05%298.4M-52.76%120.97M-15.23%178.79M-16.89%148.25M74.05%298.4M
Current changes in cash 336.33%379.92M351.38%75.22M215.26%66.64M113.76%65.28M215.07%172.78M-226.63%-160.76M-60.63%16.67M-228.04%-57.82M-6.15%30.54M-2,267.58%-150.15M
End cash Position 276.03%517.55M276.03%517.55M265.65%442.33M110.13%375.69M109.39%310.41M-53.87%137.64M-53.87%137.64M-52.76%120.97M-15.23%178.79M-16.89%148.25M
Free cash flow 286.79%239.25M32.74%70.79M312.17%72.61M108.51%64.13M164.47%31.73M-46.68%61.86M33.07%53.33M-182.86%-34.22M17.55%30.75M41.50%12M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
13.460
New Fortress Energy
NFE
11.170
Cars.com
CARS
11.640
4
Halozyme Therapeutics
HALO
65.160
5
Collegium Pharmaceutical
COLL
30.050
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.